Efficasy, safety, and pharmacokinetics results of a phase II/III, multicentre, double-blinded, randomized, cross-over study with a plasma-derived von Wilebrand Factor (WVF)/factor VIII (FVIII) concentrate (Voncento) in subjects with hemophilia A (the SWIFT-HA Study)

Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/10727

DC Field	Value	Language
dc.contributor.author	A. Klukowska	en_US
dc.contributor.author	A. Skotnicki	en_US
dc.contributor.author	T. Lissitchkov	en_US
dc.contributor.author	V. Mamonov	en_US
dc.contributor.author	E. Buevich	en_US
dc.contributor.author	K. Kuliczkowski	en_US
dc.contributor.author	S. Goranov	en_US
dc.contributor.author	J. Kolczko	en_US
dc.contributor.author	S. Stankovic	en_US
dc.contributor.author	W. Seifert	en_US
dc.date.accessioned	2021-03-08T18:38:41Z	-
dc.date.available	2021-03-08T18:38:41Z	-
dc.date.issued	2014	-
dc.identifier.uri	http://hdl.handle.net/20.500.12188/10727	-
dc.language.iso	en	en_US
dc.relation.ispartof	Haemophilia	en_US
dc.subject	hemophilia A	en_US
dc.subject	plasma-derived concentrate	en_US
dc.subject	SWIFT-HA study	en_US
dc.title	Efficasy, safety, and pharmacokinetics results of a phase II/III, multicentre, double-blinded, randomized, cross-over study with a plasma-derived von Wilebrand Factor (WVF)/factor VIII (FVIII) concentrate (Voncento) in subjects with hemophilia A (the SWIFT-HA Study)	en_US
dc.type	Proceeding article	en_US
dc.relation.conference	World Federation of Hemophilia (WFH) World Congress 2014, Melbourne, Australia	en_US
item.fulltext	With Fulltext	-
item.grantfulltext	open	-
crisitem.author.dept	Faculty of Medicine	-
Appears in Collections:	Faculty of Medicine: Conference papers

File	Size	Format
WFH 2014 World Congress Abstract book.jpg	168.66 kB	JPEG	View/Open
poster Hemophilia 2014.jpg	216.49 kB	JPEG	View/Open
abstract (Hemophilia 2014).jpg	233.12 kB	JPEG	View/Open